TY - JOUR T1 - Cutaneous manifestation of COVID-19: What have we learned an year into the pandemic? JO - Actas Dermo-Sifiliográficas T2 - AU - Sodeifian,F. AU - Mushtaq,S. AU - Rezaei,N. SN - 00017310 M3 - 10.1016/j.ad.2022.01.023 DO - 10.1016/j.ad.2022.01.023 UR - https://actasdermo.org/es-cutaneous-manifestation-covid-19-what-have-articulo-S0001731022000576 AB - Coronavirus disease-19 (COVID-19) is an emerging health situation caused by the “severe acute respiratory syndrome coronavirus 2” (SARS-CoV-2). The ongoing COVID-19 pandemic which emerged from the Chinese city of Wuhan in December 2019 has spread to over 188 countries and infected over 100 million people across the globe in over one year. Most common symptoms of COVID-19 include fever and respiratory illness. Among extrapulmonary signs associated with COVID-19, dermatological manifestations have been increasingly reported from different geographical regions. The exact incidence or prevalence of COVID-19 associated skin manifestation remains largely unknown and the pathophysiological mechanisms are still unclear. In this article, we have attempted to give a comprehensive overview of what has been learned an year into the pandemic on the epidemiology, clinical and histopathological features, pathophysiological mechanisms and clinical management of COVID-19 associated cutaneous manifestations. ER -